Literature DB >> 23160984

Serum adenosine deaminase and total immunoglobulin G correlate with markers of immune activation and inversely with CD4 counts in asymptomatic, treatment-naive HIV infection.

Hayley Ipp1, Annalise E Zemlin, Richard H Glashoff, Johan van Wyk, Naadira Vanker, Tim Reid, Linda-Gail Bekker.   

Abstract

PURPOSE: HIV-infection is characterized by aberrant immune activation and ongoing inflammation. Markers of inflammation are now recognized to have prognostic value for adverse events, independent of viral loads and CD4 counts. This study aimed to delineate a panel of affordable markers of immune activation in untreated HIV-infection that may have an impact on the management of HIV in resource-limited settings.
METHODS: This was a cross-sectional study of 86 untreated newly diagnosed HIV-infected patients and 54 matched controls attending a voluntary testing clinic in Cape Town, South Africa. Serum levels of adenosine deaminase (ADA), total immunoglobulin G (IgG), soluble CD14 and lipopolysaccharide-binding protein (LBP) were measured and correlated with CD4 counts, viral loads and expression of CD38 on CD8+ T cells.
RESULTS: ADA, IgG and LBP were all significantly increased in the HIV infected group (p < 0.0001) compared with uninfected controls. Soluble CD14 was also significantly increased (p = 0.0187). Furthermore, all these parameters correlated inversely with CD4 counts (r = -0.481 p < 0.0001; r = -0.561; p < 0.0001; r = -0.387 p = 0.0007 and r = -0.254 p = 0.0240, respectively). Only ADA correlated with viral load (r = 0.260 p = 0.0172). Importantly, ADA, IgG and LBP correlated directly with %CD38 on CD8+ T cells (r = 0.369 p < 0.0001; r = 0.284 p = 0.001; r = 0.408 p = 0.0006, respectively).
CONCLUSION: Affordable parameters such as serum ADA and IgG correlated significantly with immune activation levels and markers of disease progression in untreated HIV-infection and therefore may add value to the management of these patients in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160984     DOI: 10.1007/s10875-012-9832-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

Review 1.  HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

Authors:  Steven G Deeks; Andrew N Phillips
Journal:  BMJ       Date:  2009-01-26

2.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

3.  Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.

Authors:  Stefania Piconi; Serena Parisotto; Giuliano Rizzardini; Simone Passerini; Roberta Terzi; Barbara Argenteri; Paola Meraviglia; Amedeo Capetti; Mara Biasin; Daria Trabattoni; Mario Clerici
Journal:  Blood       Date:  2011-05-16       Impact factor: 22.113

4.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

5.  Reduction of immune activation with chloroquine therapy during chronic HIV infection.

Authors:  Shannon M Murray; Carrie M Down; David R Boulware; William M Stauffer; Winston P Cavert; Timothy W Schacker; Jason M Brenchley; Daniel C Douek
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Protein electrophoresis and immunoglobulin analysis in HIV-infected patients.

Authors:  Panagiotis A Konstantinopoulos; Bruce J Dezube; Liron Pantanowitz; Gary L Horowitz; Bruce A Beckwith
Journal:  Am J Clin Pathol       Date:  2007-10       Impact factor: 2.493

7.  The diagnostic utility of adenosine deaminase isoenzymes in tuberculous pleural effusions.

Authors:  A E Zemlin; L J Burgess; M E Carstens
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

8.  Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.

Authors:  Andrew D Redd; Djeneba Dabitao; Jay H Bream; Blake Charvat; Oliver Laeyendecker; Noah Kiwanuka; Tom Lutalo; Godfrey Kigozi; Aaron A R Tobian; Jordyn Gamiel; Jessica D Neal; Amy E Oliver; Joseph B Margolick; Nelson Sewankambo; Steven J Reynolds; Maria J Wawer; David Serwadda; Ronald H Gray; Thomas C Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-08       Impact factor: 11.205

9.  CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.

Authors:  Ana E Sousa; Jorge Carneiro; Martin Meier-Schellersheim; Zvi Grossman; Rui M M Victorino
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 10.  Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2.

Authors:  C Gakis; G Calia; A Naitana; D Pirino; G Serru
Journal:  Panminerva Med       Date:  1989 Jul-Sep       Impact factor: 5.197

View more
  5 in total

Review 1.  Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

Authors:  Daniela F Passos; Maria Rosa C Schetinger; Daniela Br Leal
Journal:  World J Virol       Date:  2015-08-12

Review 2.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

3.  Distortion of memory Vδ2 γδ T cells contributes to immune dysfunction in chronic HIV infection.

Authors:  Zhen Li; Yanmei Jiao; Yu Hu; Lianxian Cui; Dexi Chen; Hao Wu; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2014-09-15       Impact factor: 11.530

4.  Adenosine Deaminase as a Biomarker of Tenofovir Mediated Inflammation in Naïve HIV Patients.

Authors:  Francisco Miguel Conesa-Buendía; Patricia Llamas-Granda; Patricia Atencio; Alfonso Cabello; Miguel Górgolas; Raquel Largo; Gabriel Herrero-Beaumont; Aránzazu Mediero
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

5.  E-Selectin and markers of HIV disease severity, inflammation and coagulation in HIV-infected treatment-naïve individuals.

Authors:  Madelein Hoffman; Hayley Ipp; Dineo V Phatlhane; Rajiv T Erasmus; Annalise E Zemlin
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.